TrialCancer medicine2021

Multicentric phase II trial of TI-CE high-dose chemotherapy with therapeutic drug monitoring of carboplatin in patients with relapsed advanced germ cell tumors.

Christine Chevreau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.